Venture Partners L P Us VIII's Net Worth

$740 Million

Estimate Recalculated Feb 22, 2024 09:40PM EST

Who is Venture Partners L P Us VIII?

Venture Partners L P Us VIII has an estimated net worth of $740 Million. This is based on reported shares across multiple companies, which include LEADIS TECHNOLOGY INC, Altus Pharmaceuticals Inc., IMPERVA INC, Guidewire Software, Inc., AtriCure, Inc., MAXLINEAR INC, and OncoMed Pharmaceuticals Inc.

SEC CIK

Venture Partners L P Us VIII's CIK is 0001225444

Past Insider Trading and Trends

2010 was Venture Partners L P Us VIII's most active year for acquiring shares with 16 total transactions. Venture Partners L P Us VIII's most active month to acquire stocks was the month of December. 2012 was Venture Partners L P Us VIII's most active year for disposing of shares, totalling 42 transactions. Venture Partners L P Us VIII's most active month to dispose stocks was the month of July. 2011 saw Venture Partners L P Us VIII paying a total of $2,752,542.00 for 3,251,682 shares, this is the most they've acquired in one year. In 2012 Venture Partners L P Us VIII cashed out on 20,810,518 shares for a total of $94,728,266.34, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

LEADIS TECHNOLOGY INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-33.31%
-1.01M
2.02M
Jul 26
Form 4
-24.99%
-1.01M
3.02M
May 25
Form 4
-19.99%
-1.00M
4M
Feb 1
Form 4
5.11M
5.11M
Jun 21
Form 3/A
0
0
Form 3
0
0
No matching records found

Altus Pharmaceuticals Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.96%
-300.00K
$0.32
-$97,290.00
2.71M
Sep 14
Form 4
3.01M
3.01M
Jan 31
Form 3
0
0
No matching records found

AtriCure, Inc. (ATRC) Snapshot price: $33.02

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-18.89%
-352.58K
1.51M
Jun 13
Form 4
-15.87%
-357.62K
$9.44
-$47,578.88
1.9M
Jun 6 - Jun 7
Form 4
+0.38%
8.47K
$5.62
$14,076.53
2.25M
Aug 10
Form 4
2.24M
$11.16
-$3,037,952.88
2.24M
Aug 10
Form 3
0
0
Form 3
0
0
No matching records found

MAXLINEAR INC (MXL) Snapshot price: $17.565

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Aug 21
Form 4
-100.00%
-4.88K
$4.20
-$20,484.75
0
May 30
Form 4
4.88K
4.88K
May 15
Form 4
-100.00%
-6.96K
$8.95
-$62,339.74
0
May 27
Form 4
+5.50%
363
$8.93
-$40,279.08
6.96K
May 25 - May 26
Form 4
-36.82%
-3.85K
$11.54
-$44,399.37
6.6K
Feb 15
Form 4
10.45K
10.45K
Feb 7
Form 4
-100.00%
-4.42K
$10.54
-$46,520.86
0
Nov 29
Form 4/A
-33.10%
-1.45K
$10.52
-$15,281.20
2.94K
Nov 15
Form 4
-33.56%
-2.22K
$10.52
-$23,347.74
4.39K
Nov 15
Form 4
6.62K
6.62K
Nov 5
Form 4
-100.00%
-5.44M
$14.00
-$7,954,730.00
0
Mar 29
Form 4
5.44M
5.44M
Mar 29
Form 3
0
0
No matching records found

OncoMed Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found